Science
Mechanism of Action
The direct mechanistic pathways by which RH-POLYPEPTIDE-17 interacts with skin cells or influences dermal processes have not been thoroughly elucidated. Available information frequently conflates this specific peptide with Myristoyl Pentapeptide-17, which possesses distinct, well-researched biological functions.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Specific data regarding the optimal pH range for stability and general formulation considerations for RH-POLYPEPTIDE-17 are currently unavailable in reviewed literature.
Safety
Safety Profile
Specific regulatory safety assessments from bodies such as CIR, SCCS, or FDA for RH-POLYPEPTIDE-17 have not been identified. While listed with potential conditioning roles, the ingredient lacks specific ratings or established benefits according to some sources, often being confused with a distinct peptide, Myristoyl Pentapeptide-17. Consequently, a definitive safety profile for RH-POLYPEPTIDE-17 cannot be concluded based on current publicly available data.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to the profound lack of specific clinical efficacy, safety data, and a clearly defined mechanism of action for RH-POLYPEPTIDE-17, its inclusion in precision skincare formulations is currently not supported by sufficient scientific evidence.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources